Podcasts about johns hopkins bloomberg school

About this episode: Back-to-back crises of the opioid epidemic and COVID-19 have pummeled American communities, eroding trust in public health. But what if restoring that trust could start with a simple conversation? In this episode: Maggie Bartlett shares how she's using her platform as co-host of the podcast, “Why Should I Trust You?”, to forge human connections with those who feel left out of public health conversations and to debunk misinformation about measles, vaccines, and corporate influence. Watch the video episode on YouTube: https://youtu.be/zCx9YY9EBWk Guest: Maggie L. Bartlett, PhD, is an assistant research professor in Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health and the co-host of “Why Should I Trust You?”. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: Inside A Rare Conversation Between MAHA Grassroots and Public Health Leaders—Why Should I Trust You? What I'm Learning from MAHA—Your Local Epidemiologist Why Should I Trust You?—www.whyshoulditrustyou.net Transcript Information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: Official measures of homeless Americans omit the millions of individuals and families that make up the “working homeless”—a segment of the population that, despite working full time, cannot secure stable housing. In this episode: Journalist Brian Goldstone pulls back the curtain on America's worsening homelessness crisis and interrogates the fractured relationship between employment and financial stability. Guest: Brian Goldstone, PhD, is a journalist and the author of There Is No Place for Us: Working and Homeless in America. His work has appeared in The New York Times, Harper's, The New Republic, Guernica, and Jacobin. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: There Is No Place for Us—Penguin Random House The invisible homeless crisis that official statistics miss—Vox The New American Homeless—The New Republic Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

This week on Health Matters, we bust myths about seed oils and learn the difference between saturated fats and unsaturated fats. Dr. David Majure, a cardiologist at NewYork-Presbyterian and Weill Cornell Medicine, explains different types of fat and fatty acids, such as Omega-3 and Omega-6, including where they come from and what they mean for our health. He also shares the results of several studies that help get to the bottom of the benefits and risks of seed oils.___Dr. David Majure is the medical director of the Heart Transplant Service at NewYork-Presbyterian/Weill Cornell Medical Center and assistant professor of medicine at Weill Cornell Medicine. He specializes in the care of patients with heart failure, patients requiring or who have a heart transplant or ventricular assist device (LVAD), and patients with pulmonary hypertension. Dr. Majure received his medical degree from The Johns Hopkins School of Medicine as well as a Masters in Public Health from the Johns Hopkins Bloomberg School of Public Health. He completed his training in cardiology and advanced heart failure at the University of California, San Francisco, where he also served as an assistant clinical professor of medicine. He subsequently served as director of Research of the Advanced Heart Failure Program at the MedStar Washington Hospital Center in Washington, D.C and Director of Mechanical Circulatory Support at North Shore University Hospital, where he developed the left ventricular assist device (LVAD) program. He has contributed extensively to research and has served as principal investigator in multiple clinical trials, exploring all aspects of advanced heart failure. Dr. Majure has been recognized as a Castle Connolly Top Doctor since 2020.___Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday.If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine. To learn more visit: https://healthmatters.nyp.org

About this episode: Since the fifth grade, high schooler Nayesha Diwan has been fascinated by the world of public health. Throughout her childhood and teenage years, she has immersed herself in research and advocacy, delivering speeches at her state's capitol and interning at an elite neurophysiology lab. In this episode: Nayesha explains how her mother's cancer diagnosis drew her to public health and reminds us how complex and impactful the field can be. Guest: Nayesha Diwan is a rising high school junior with a passion for science, health care, and public health. She is a semifinalist for the USA Biology Olympiad exam and is currently researching the blood brain barrier and neurological disorders. Nayesha is the host of the Global Health Frontlines podcast. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: Global Health Frontlines—Spotify Influence the Choice—www.influencethechoice.org Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Ever walk out of a shift and feel like the hospital came home with you? In medicine, the mental residue can cling long after the work day is done. One way to address this is boundary rituals, deliberate actions designed to process the day and allow you to leave work at work, be more present when you get home, and possibly even sleep better. As a bonus, the ability to disengage from work is one of the strongest predictors of reduced burnout.In this episode, Mohamed Hagahmed, MD, shares how he creates this boundary—through small rituals of gratitude, stillness, and reflection. From growing up as a refugee to serving as a sideline physician for the Pittsburgh Steelers, Dr. Hagahmed's path has been shaped by resilience, culture, and care. He explains how he learned to stop carrying unfixable wounds home, why kindness is clinical armor, and how tiny acts of self-compassion can protect meaning in medicine.Guest Bio: Mohamed Hagahmed, MD a Clinical Assistant Professor of Emergency Medicine at the University of Pittsburgh, Associate Medical Director at the Center for Emergency Medicine, and EMS Medical Director for several systems in Western Pennsylvania. On top of that, he works in high-acuity emergency departments across the region. He's a graduate of Johns Hopkins Bloomberg School of Public Health, passionate about resuscitation, critical care, and toxicology education. And he's the creator and host of EMERGE in EM, a podcast focused on emergency medicine education and global health empowerment.We Discuss: Growing up as a refugee and finding purpose in emergency medicineThe toll of moral injury and why staying closed and rigid nearly broke himSmall rituals that help shed the emotional residue of a shiftUsing gratitude and stillness as tools for resilienceHow changing clothes, music, and even snacks can protect emotional healthTurning frustration into advocacy for immigrant health and systemic changeAdvice for new attendings on protecting the threshold between work and homeMentioned in this episode:5 Free Tools To Make Medical Practice EasierScripts for your least favorite conversations. The quick and dirty guide to calling consults. A 10-minute "Driveway Debrief" to switch off from work. My favorite documentation templates. Step-by-step guide for delivering the news of death. Free Resources LinkDistilled Kickassery Every Other SaturdaySign up for our Newsletter

About this episode: The reconciliation bill passed by Congress in July is set to unravel key aspects of the Affordable Care Act that have expanded health coverage to millions of Americans. In this episode: One of the architects of the ACA, Liz Fowler, outlines how work requirements, truncated enrollment periods, and higher premiums will change health care for Americans on Medicaid and Medicare and for those buying coverage through their state's marketplace. Guest: Elizabeth Fowler, PhD, JD, is a distinguished scholar in Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health and previously served as the director of the Innovation Center at the Centers for Medicare & Medicaid Services. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: How New Federal Legislation Will Affect Health Care Costs and Access for Americans—Johns Hopkins Bloomberg School of Public Health When Do the One Big Beautiful Bill Act's Health Care Provisions Go Into Effect?—Center for American Progress Health Provisions in the 2025 Federal Budget Reconciliation Law—KFF Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode:  Sickle cell disease affects an estimated 100,000 people in the United States. Recent advancements in gene therapies and medicines like hydroxyurea are diminishing extreme pain, reducing strokes, and extending survival times for those afflicted by the disease. In this episode: leading sickle cell disease expert Dr. Mark Gladwin explains how revolutionary new treatments work and discusses the challenges to access to life-saving care. Guest: Dr. Mark Gladwin is a physician-scientist and the Dean of the University of Maryland School of Medicine and Vice President for Medical Affairs at the University of Maryland, Baltimore. His research focuses include sickle cell disease and hypertension. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle—CNBC Gene Therapy: What You Need to Know—Sickle Cell Disease Association of American No More Pain: Breakthrough Sickle Cell Treatment from Johns Hopkins Offers Curative Potential—Johns Hopkins School of Medicine Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: Fall vaccines for flu, RSV, and—more recently—COVID have long followed a uniform rollout schedule allowing clinics and pharmacies ample time to order and administer shots. But that process looks different this year, raising concerns about access. In this episode: Katelyn Jetelina, publisher of Your Local Epidemiologist, explains how changes to the CDC's Advisory Committee on Immunization Practices (ACIP) and the FDA are pushing back the timeline and changing recommendations for routine vaccinations. Guest: Katelyn Jetelina, PhD, MPH, is an epidemiologist and scientific communicator. She is the co-founder of Health Trust Initiative, an adjunct professor at Yale School of Public Health, and a Senior Scientific Advisor to several government and non-profit agencies, including the CDC. In addition, Jetelina is the publisher of Your Local Epidemiologist. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: What's the plan for fall vaccines? If you're confused, you're not alone—Your Local Epidemiologist Covid cases rising in US as officials plan to restrict booster vaccines—The Guardian Will New Vaccine Recommendations Affect Your Fall Flu Shot?—AARP Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

 It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: cancer reserach may lead to T1D treatment, GLP-1 oral pill moves forward, Tandem pharmacy moves, Medtronic-Abbott sensor unveield, parents of kids with T1D see income drop, Mannkind submits Afrezza for pediatrics, diabetes scholarships and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Cornell researchers have developed an implant system that can treat type 1 diabetes by supplying extra oxygen to densely packed insulin-secreting cells, without the need for immunosuppression. The system could also potentially provide long-term treatment for a range of chronic diseases. This lab has produced previous implantable devices that have proved effective in controlling blood sugar in diabetic mice, but they can only last so long. "It's the proof of concept. We really proved that oxygenation is important, and oxygenation will support high cell-density capsules," Tempelman said. "The capsules are immune protective and last for a long time without having some kind of fouling of the membrane. The body never likes it when you put a foreign substance in. So that's the engineering in the Ma Lab, to look for materials and coatings for the materials that are immune protective, but also don't invoke excess response from the body because of the material." The next step will be to implant the system in a pig model, and also test it with human stem cells. The researchers are interested in eventually trying to use the system for implanting different cell types in humans for long-term treatment of chronic diseases, according to Tempelman, who is CEO of Persista Bio Inc., a new startup she founded with Ma and Flanders that is licensing these technologies. https://medicalxpress.com/news/2025-08-implant-diabetes-oxygenating-insulin-cells.html XX Mayo Clinic cancer research may be big news for T1D. After identifying a sugar molecule that cancer cells use on their surfaces to hide from the immune system, the researchers have found the same molecule may eventually help in the treatment of type 1. Cancer cells use a variety of methods to evade immune response, including coating themselves in a sugar molecule known as sialic acid. The researchers found in a preclinical model of type 1 diabetes that it's possible to dress up beta cells with the same sugar molecule, enabling the immune system to tolerate the cells. The findings show that it's possible to engineer beta cells that do not prompt an immune response   In the preclinical models, the team found that the engineered cells were 90% effective in preventing the development of type 1 diabetes. The beta cells that are typically destroyed by the immune system in type 1 diabetes were preserved.     https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-find-sugar-coating-cells-can-protect-those-typically-destroyed-in-type-1-diabetes/ XX A daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as the popular injectable drugs Mounjaro and Ozempic, according to results of a clinical trial announced by Eli Lilly on Thursday morning.   The drug, orforglipron, is a GLP-1, a class of drugs that have become blockbusters because of their weight-loss effects. But the GLP-1s on the market now are expensive, must be kept refrigerated and must be injected. A pill that produces similar results has the potential to become far more widely used, though it is also expected to be expensive.   Lilly said it would seek approval from the Food and Drug Administration later this year to market orforglipron for obesity and early in 2026 for diabetes. https://www.nytimes.com/2025/04/17/health/pill-glp-1-eli-lilly.html XX Use of diabetes technology has dramatically increased and glycemic control has improved among people with type 1 diabetes (T1D) in the US over the past 15 years, but at the same time, overall achievement of an A1c level < 7% remains low and socioeconomic and racial disparities have widened. These findings came from an analysis of national electronic health records of nearly 200,000 children and adults with T1D by Michael Fang, PhD, of the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues. The study was published online on August 11, 2025, in JAMA Network Open. Use of continuous glucose monitors (CGMs) increased substantially from 2009-2011 to 2021-2023, from less than 5% in both children and adults to more than 80% and over half, respectively. While A1c levels did drop over the 15 years, just 1 in 5 children and slightly over a quarter of adults achieved a level < 7%. The average A1c level stayed above 8%, with ethnic minorities and low-income patients seeing the smallest gains.       https://www.medscape.com/viewarticle/diabetes-tech-use-rise-a1c-reductions-still-lag-2025a1000lc9 XX Inflammation may predict how well people with diabetes respond to depression treatment, and the effects differ dramatically between type 1 and type 2 diabetes. Diabetes and depression often appear together. Indeed, depression is more than three times more prevalent in people with type 1 diabetes (T1D) and nearly twice as prevalent in people with type 2 diabetes (T2D). When they appear together, treatment for depression can vary widely. In a new study, researchers from the German Diabetes Center (DDZ), the Research Institute of the Diabetes Academy Mergentheim (FIDAM), and the German Center for Diabetes Research (DZD) investigated how inflammation in the body relates to improvement in depression symptoms in people with T1D and T2D. The researchers combined data from three previous German randomized clinical trials that aimed to reduce elevated depressive symptoms and diabetes distress in people with type 1 or type 2 diabetes. Diabetes distress is characterized by feelings of overwhelm, frustration, guilt and worry about diabetes management and its potential complications. A total of 332 participants with T1D and 189 with T2D who had completed both a baseline and 12-month follow-up examination were included in the present study. Measures included depression using the Center for Epidemiological Studies Depression scale (CES-D), blood tests for 76 inflammatory biomarkers, and symptoms broken down into cognitive-affective (e.g., feeling hopeless), somatic (e.g., poor sleep, fatigue), and anhedonia (loss of pleasure) clusters.   After adjusting for factors like age, body mass index (BMI), diabetes duration, cholesterol, and co-existing illnesses, the researchers found that in patients with T1D, higher baseline inflammation was linked to smaller improvements in depression. Inflammation seemed to be more connected to physical/somatic symptoms in T1D patients. In those with T2D, higher baseline inflammation was linked to greater improvements in depression. For these patients, the effect was strongest for cognitive-affective and anhedonia – so, emotional and motivational – symptoms.   The researchers weren't sure what caused the difference between T1D and T2D, but they suggest it might be due to the different forms of immune activation seen in each condition. That is, autoimmune processes in type 1 and metabolic inflammation in type 2. https://newatlas.com/health-wellbeing/inflammation-diabetes-depression-treatment/ XX Parents of children diagnosed with type 1 diabetes suffer an income drop in the years following the diagnosis. The impact is more pronounced in mothers, especially mothers of children diagnosed in preschool years. And these findings come from a European study.. not the US. Previous research has shown that parents of children with type 1 diabetes are at increased risk of stress-related symptoms and may need to reduce their working hours. "In our study, we observed reduced parental work-related incomes in the years following the child's type 1 diabetes diagnosis. The drop was larger in mothers than in fathers. Since mothers earned significantly less than fathers in absolute terms, even before the child fell ill, the relative drop in mothers was 6.6% the year following diagnosis compared to 1.5% in fathers. We further note the greatest impact on work-related incomes in mothers of children diagnosed at preschool age," says Beatrice Kennedy, physician at the Endocrine and Diabetes unit at Uppsala University Hospital and Associate Professor of Medical Epidemiology at Uppsala University, who led the study. This is a huge study, builds on data from national population and health registers and the Swedish Child Diabetes Register (Swediabkids). The study includes the parents of more than 13,000 children diagnosed with type 1 diabetes in Sweden in 1993−2014, as well as more than half a million parents in the general population who have children not diagnosed with diabetes.   The researchers observed that the maternal pension-qualifying incomes (a composite outcome including work-related income and societal benefits) initially increased after the child's diagnosis. This was attributable to mothers applying for the parental care allowance from the Swedish Social Insurance Agency. The parental care allowance was intended to compensate for disease-related loss of work-related income and contribute toward disease-specific costs.   When the research team investigated long-term effects in mothers, they found that the pension-qualifying incomes gradually decreased after eight years, and had not recovered by the end of follow-up − 17 years after the children were diagnosed. https://www.news-medical.net/news/20250811/Mothers-face-greater-financial-impact-following-childe28099s-type-1-diabetes-diagnosis.aspx XX The U.S. Department of Justice has reached a settlement with Metro Nashville Public Schools after allegations that the district violated the Americans with Disabilities Act.   The parents of a student at the Ross Early Learning Center requested that the school monitor their child's glucose monitor. Investigators found the school refused to do so, despite the child's Type 1 Diabetes diagnosis.   As part of the settlement, MNPS agreed to change its policies to allow the use of these devices, ensure trained staff can monitor them throughout the entire school day and at school activities, and improve communication with parents. https://www.wsmv.com/2025/08/12/metro-nashville-public-schools-settles-allegations-it-discriminated-against-students-with-diabetes/ XX Modular Medical has unveiled Pivot, its next-generation insulin patch pump technology aimed at simplifying diabetes care. The company announced its new pump for “almost-pumpers” at the Association of Diabetes Care & Education Specialists (“ADCES”) Conference in Phoenix, Arizona this weekend. It aims for Pivot to target adults with a user-friendly, affordable design.   Modular Medical's current pump, the MODD1, won FDA clearance nearly a year ago. It features new microfluidics technology to allow for the low-cost pumping of insulin. The system has a reservoir size of 300 units/3mL. Users can monitor the pump activity with their cell phone and do not require an external controller. The pump uses a provided, single-use, disposable battery.   The company announced recently that it validated its insulin pump cartridge line for human-use production in the U.S. Days later, it reported the first human use of the MODD1 pump.   Now, it has taken the next steps with the debut of a next-gen pump, set for FDA submission in October.   Modular Medical also gamifies diabetes care The company also said ADCES is the place where it will showcase the first playable level of its new Pivot pump gamified trainin module. Level Ex, a developer of medical games, develops the module.   Modular Medical said gamification offers a way to make medical training more effective and efficient while improving information retention. Given the complexity in pump uptake, the company hopes to provide an easy way to bring its technology to clinicians and patients.   The company expects to have training modules available at the same time as the pump's planned launch in 2026.   “Level One is free because diabetes mastery shouldn't come with a price tag,” Sam Glassenberg, CEO of Level Ex, said. “Modular Medical is breaking barriers too – bringing pump therapy to more people through smart, accessible design. Together, we intend to make diabetes management simpler and more inclusive.   “People learn best through play – and we believe they want to learn about insulin pumps the same way. In Level One, players aren't just mastering diabetes management through gameplay – they're asking to ‘play' with pumps: to explore how they work, understand their benefits, and build confidence before using them in real life. Our partnership with Modular Medical helps make that possible.” https://www.drugdeliverybusiness.com/modular-medical-unveils-next-gen-insulin-pump/ XX On Tuesday, 12 August 2025, Tandem Diabetes Care (NASDAQ:TNDM) presented at the Canaccord Genuity's 45th Annual Growth Conference, outlining strategic shifts and market focus. The company highlighted its plans for commercial transformation in the U.S. and expansion in international markets, alongside addressing competitive challenges and regulatory impacts. While optimistic about growth in Outside the U.S. (OUS) markets, Tandem is navigating a more competitive landscape domestically. We have entered into the pharmacy channel with Mobi only. And so as Mobi's been building up volume, we're getting experience and we're really learning and understanding what pharmacy offers to us. And the proof points have proved out the thesis I said earlier, which is it can really reduce that barrier for patients, is the out of pocket cost. And so we've decided to accelerate our strategy and where we were starting just with Mobi, we are now moving t slim supplies into the pharmacy channel, and that will kick into gear in the fourth quarter. So as people are looking at the cadence of sales for the remainder of the year with this reframing, many folks are seeing what looks like a a might be an outsized fourth quarter and and having trouble understanding those dynamics. We'll be adding the tSIM supplies to those contracts. We also have more coverage. We will have it in the coming weeks effective this year, so we will be increasing that 30% rate before the end of the year. And then, obviously, everyone's in the same cycle right now already negotiating and discussing their 2026 coverage. And so 30% is the floor.   We do expect to continue to grow that coverage in the coming years, and ultimately have a much broader access. Absolutely. It's an exciting technology that allows for us to have an infusion set that extends the wear time from three days to up to seven days. So we're able to use that as part of an independent infusion set, which would then be used with the t slim and with the mobi pump today. But we're also using that same technology as part of the site that's used for mobi when you use it with a tubeless cartridge. So next year, we will launch Mobi in a patch configuration.   It uses the same pump that's available today, but by using a modified cartridge, you're able to wear it as a patch pump. So one of the things we announced on the call is that we're using this extended wear technology as part of that site. So what it allows you to do is to change the portion that you wear in your skin separate from the timing of when you change the insulin cartridge. So it allows for that extended wear time, reduction of burden to the patient, which is especially important for higher volume insulin users as we expand into type two. So from here, we will launch the extended wear site next year along with we'll do a separate regulatory filing for the cartridge portion for Mobi that includes this extended wear technology as a predicate device. So that's another filing that we'll need to do, but we have the clearance today for the independent infusion set, but we'll file another five ten k for use of the extended wear technology as part of the tubeless Mobi feature. https://za.investing.com/news/transcripts/tandem-diabetes-at-canaccord-conference-strategic-shifts-and-market-focus-93CH-3834464 XX MannKind today announced a significant regulatory submission and a large financing agreement with Blackstone. The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said.   First, the Danbury, Connecticut-based company announced that it submitted a supplemental Biologics License Application (sBLA) for Afrezza, its inhaled insulin product, in the pediatric population.   MannKind Director of Medical and Scientific Engagement Joanne Rinker, MS, RDN, BC-ADM, CDCES, LDN, FADCES, told Drug Delivery Business News at ADA 2025 that a submission was on the way for children and adolescents aged 4-17 years old. Further data shared at ADA found Afrezza both safe and effective in that age range.   Afrezza is a fast-acting insulin formulation delivered through an inhaler device. MannKind engineered the mechanical inhaler device to slowly bring powder into the lung. A small compartment opens for the insertion of the insulin cartridge, then the user closes it. The only other component is a mouthpiece for the sake of cleanliness. Then, the inhalation takes just two seconds. It requires no electronics or extra components.   The company expects a review acceptance decision early in the fourth quarter of 2025.   “The submission of our supplemental Biologics License Application (sBLA) for Afrezza in pediatric patients is a meaningful milestone for MannKind and people living with diabetes,” said Michael Castagna, CEO of MannKind Corporation.   Additional funding provides a significant boost for MannKind MannKind also announced a strategic financing agreement with funds managed by Blackstone worth up to $500 million. The financing provides MannKind with non-dilutive capital to advance its short- and long-term growth strategies.   This senior secured credit facility includes a $75 million initial term loan funded at closing. It then has a $125 million delayed draw term loan available for the next 24 months. Finally, it features an additional $300 million uncommitted delayed draw term loan available at the mutual consent of MannKind and Blackstone.   The facility bears interest at a calculated SOFR variable rate plus 4.75% and matures in August 2030.   “This strategic financing significantly increases our operating flexibility and provides us substantial access to non-dilutive capital on favorable terms, complementing our strong cash position,” said Castagna. “The funding will support the expansion of our commercial team in preparation for the anticipated launch of the pediatric indication for Afrezza, if approved, continued pipeline advancement, potential business development opportunities, and general corporate purposes. Partnering with the Blackstone team on this transaction positions us to accelerate our next phase of growth and innovation.” https://www.drugdeliverybusiness.com/mannkind-fda-submission-pediatrics-500m-blackstone/ XX   Medtronic MiniMed Abbott Instinct Sensor [Image from Medtronic Diabetes on LinkedIn] The Medtronic Diabetes business today took to social media to share an early preview of a new integrated Abbott sensor for its insulin delivery systems. Medtronic Diabetes — soon to be MiniMed after its planned separation from the medtech giant – said in the post that the new sensor specifically designed for its own systems is called “Instinct.”   “Get a sneak peek at what's coming next: the Instinct sensor,” the business unit's account wrote. “Made by Abbott, the Instinct sensor is designed exclusively for MiniMed systems. We'll share more details about the Instinct sensor when it's commercially available.”   The sensor, built on the Abbott FreeStyle Libre platform, reflects “the power of the partnership,” Abbott EVP, Diabetes Care, Chris Scoggins, told Drug Delivery Business News earlier this year.   Medtronic and Abbott — two of the largest diabetes tech companies in the world — announced a year ago that they entered into a global partnership pairing Abbott continuous glucose monitors (CGMs) with Medtronic insulin delivery systems.   The partnership aims to collaborate on a system based on Abbott's FreeStyle Libre CGMs with Medtronic's automated insulin delivery technology (the latest generation being the MiniMed 780G) and smart insulin pen systems, such as the InPen system.   Read more about Medtronic, Abbott and the rest of the diabetes tech industry in our free Diabetes Technology Special Report. Medtronic's systems previously used its own CGMs, such as the Guardian 4 and the Simplera platform, and the company intends to continue using those systems as part of a comprehensive CGM portfolio. Under the companies' agreement, the systems would be sold exclusively by Medtronic — including the Abbott CGM.   The companies brought the partnership a step further in April when Medtronic announced the submission of an interoperable pump with the Abbott sensor technology to the FDA. They plan to share more details following the expected FDA clearance, which remains pending.   Management also recently emphasized the multi-year nature of the partnership, meaning Medtronic could pair current and future pumps with other Abbott sensors in the future. That could hint at integration with the company's future dual glucose-ketone monitor, as a number of pump makers have already announced collaborations to pair their systems with the sensor once it hits the market. https://www.drugdeliverybusiness.com/medtronic-diabetes-previews-abbott-sensor-minimed/ XX Governor Glenn Youngkin joined Civica officials at the company's Petersburg manufacturing facility to announce a $3 million grant from the Commonwealth of Virginia to accelerate Civica's efforts to develop and produce affordable insulin for Americans living with diabetes.   CivicaRx Logo   "We are proud to partner with Civica in their mission to make essential medicines more accessible," said Governor Youngkin. "This investment reflects our belief in the power of public-private collaboration to improve lives and strengthen communities."   These funds will support the production of insulin aspart, a rapid-acting human insulin analog used to regulate blood sugar in adults and children with diabetes. Civica plans to produce both rapid- and long-acting insulins at its state-of-the-art manufacturing facility in Petersburg, Va., where the company now employs more than 200 skilled workers.1 Over 8 million people living with diabetes need rapid-acting and/or long-acting insulin.   The Governor also announced that he had officially proclaimed August 7 – 14 2025 'Life Sciences Week' demonstrating the Commonwealth's commitment to "accelerating the advancement of the life sciences through public-private partnerships, STEM education, workforce development, and sustained investment in research and development."   "We are grateful for the Commonwealth's support," said Ned McCoy, Civica's President and CEO. "This funding will help us move closer toward our goal of ensuring that no one has to choose between insulin and other basic needs."   Civica and Virginia officials were joined by Lynn Starr, Chief Global Advocacy Officer of Breakthrough T1D, the leading global type 1 diabetes research and advocacy organization.   "More than one million American adults live with type 1 diabetes, and many still, sadly, ration their insulin, due to the prohibitively high cost of this necessary medication," said Starr.  "Civica's work will help to make insulin more affordable for people across the country."   Breakthrough T1D is among more than two dozen organizations and philanthropists, along with the states of Virginia and California, that have partnered with Civica to support the development of affordable insulins.   Civica's insulin initiative aims to provide patients with predictable, transparent pricing — no more than $30 per vial or $55 for a box of five pens — regardless of insurance status.   About Civica Civica is a nonprofit pharmaceutical company established to address drug shortages. It was founded by a group of U.S. health systems and philanthropies who, after more than a decade of chronic shortages, recognized that the market was not self-correcting and that a different approach is required. Civica works to deliver a safe, stable, and affordable supply of essential medicines to U.S. patients.   Media Contact: Liz Power liz.power@civicarx.org +1 860 501 3849 https://cbs4indy.com/business/press-releases/cision/20250807NY46213/governor-glenn-youngkin-announces-3-million-grant-to-support-civicas-affordable-insulin-programs/ XX If you or someone you love is living with diabetes, you already know the fight isn't just medical—it's financial, too. Between daily supplies, doctor visits, and long-term care, the cost of managing type 1 or type 2 diabetes can be overwhelming. Add college or trade school into the equation, and suddenly staying healthy competes with building a future. That's where scholarships for students with diabetes—like Beyond Scholars and others listed here—step in.   Whether you're headed to a university, a two-year college, or a hands-on trade program, these opportunities were created to ease the load.   Scholarships for students with diabetes Beyond Scholars (from Beyond Type 1): $10,000 for recently graduated high school seniors with type 1 diabetes or type 2 diabetes entering college or trade school. This is one of the largest needs-based diabetes scholarships in the United States. This year, awardees will also receive 6 months of wellness coaching through Risely Health.   Applications open: July 25, 2025 Deadline: August 29, 2025 Winners announced: October 2025 https://beyondtype1.org/beyond-scholars-diabetes-scholarships-college-trade-school/ XX Nick Jonas and Kyle Rudolph are using their platforms for a good cause.   On Tuesday, Aug. 12, the singer and the former NFL tight end (via his professional fundraising platform Alltroo) announced they're teaming up to launch a rally featuring a fan-coveted prize: a custom 2025 Volkswagen ID. Buzz electric bus that the Jonas Brothers have brought along for their 20th anniversary tour.   “Ten years ago, we hit the road with a goal to change what it means to live with diabetes. Since then, Beyond Type 1 has grown into the world's largest digital diabetes community, offering the tools, education, and peer support needed to not only survive but thrive with diabetes,” Jonas, who co-founded Beyond Type 1 (a nonprofit that advocates for those living with diabetes), says in a statement.     “We've challenged stigma, built community, provided life-saving resources, and collectively driven global innovation toward prevention and cure. This milestone is a moment to rally even more support for our mission, and partnering with Alltroo helps us do that in a powerful, engaging way.”   Related Stories Nick Jonas on Managing His Diabetes: 'The Mental and Emotional Health Aspect Is Really Important' nick jonas Nick Jonas Says He Was Diagnosed with Diabetes After Joe Told Their Parents: 'Something's Really Wrong' Joe Jonas and Nick Jonas attend the amfAR Cannes Gala 30th edition at Hotel du Cap-Eden-Roc on May 23, 2024 For Rudolph, the campaign is about "celebrating Beyond Type 1's incredible work over the past decade, and standing behind their vision of a world where everyone with diabetes — or at risk of it — has access to the knowledge, care and support needed for early diagnosis and lifelong health."   While the rally is live on Alltroo.com, fans can also scan QR codes available at all 36 Jonas Brothers concert stops to enter for a chance to win the electric bus. (A winner will be selected on November 14, which is World Diabetes Day.)   Jonas, 32, has long been open about his Type 1 diabetes diagnosis at 13 years old. "I had this kind of wrench thrown into things when I was diagnosed and it took a while to figure out how to count carbs to properly dose for insulin and what things would affect me in different ways," he previously told PEOPLE.   "When I was first diagnosed, I was sitting in the hospital and was scared to death, honestly, while I was learning about how to manage this new thing I was dealing with," Jonas recalled. "It would have been amazing to have someone to look at at that time to say, oh, this is a person living with it and they're following their dreams. They're doing what they want to do with their lives and not letting it slow them down."           https://people.com/nick-jonas-kyle-rudolph-launch-fan-rally-diabetes-awareness-11788684

About this episode: The Department of Health and Human Services has cancelled nearly $500 million in funding for the development of mRNA vaccines, including for vaccines against potential new pandemic threats. In this episode: Professor Bill Moss delves into the misinformation surrounding mRNA vaccines, explains their potential to treat diseases like cancer and HIV, and warns of the national security threats posed by cuts to development. Guest: Dr. Bill Moss, MPH, is an infectious disease specialist and the executive director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs. Show links and related content: Johns Hopkins expert speaks on ripple effect of federal cuts to mRNA vaccine contracts—WBAL-TV 11 How Cuts to mRNA Vaccine Development Will Set the U.S. Back—Johns Hopkins Bloomberg School of Public Health What to know about mRNA vaccines as Trump admin pulls funding—Axios For mRNA Vaccines, COVID-19 Is Just the Beginning—Johns Hopkins Bloomberg School of Public Health Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: Since 2010, the nonprofit ChopChop Family has published magazines, cookbooks, and other tools to help pediatricians and nutrition educators inform families about the positive health outcomes of cooking nutritious foods. But deep cuts to SNAP-Ed, the federally-funded nutrition education program, are placing programs like ChopChop Family in limbo. In this episode: ChopChop Family founder and president Sally Sampson explains how the rapid rollback of SNAP-Ed is crippling nutrition education. Guest: Sally Sampson is a cookbook author and the founder and president of ChopChop Family, a nonprofit publisher of cooking magazines, cookbooks, digital content, cooking curricula, and learning decks for children and families. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Budget cuts knock down a ‘pillar of public health,' ending nutrition education—STAT ChopChop Podcast—Apple Podcasts ChopChop Family Newsletter—Substack Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: As the United States grows more polarized along regional, political, and ideological lines, it is critical to resolve conflict civilly—particularly when it comes to pressing public health concerns that implicate all of us. In this episode: Peace building experts David Addiss and John Paul Lederach draw on their careers in conflict resolution and public health to share strategies for building relationships, restoring trustworthiness, and fostering solutions-oriented conversations to bridge ideological gaps. Guest: Dr. David Addiss, MPH, is a public health doctor whose career has involved migrant health, mountain medicine, neglected tropical diseases, research, philanthropy, and global health. He is the Director of the Focus Area for Compassion and Ethics at the Task Force for Global Health. John Paul Lederach, PhD, is Professor Emeritus at the University of Notre Dame and a Senior Fellow with Humanity United. He is widely known for the development of culturally-based approaches to conflict transformation and the design and implementation of integrative and strategic approaches to peace building. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: A Recipe for Cooling Down American Politics—Washington Post Facing Down a Civil War—www.johnpaullederach.com Here To Understand: How Braver Angels Is Orchestrating Tough Public Health Conversations—Public Health On Call (June 2025) Peacebuilding to Help Mend A Broken World—Public Health On Call (December 2023) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: Trying to save money on antibiotics, GLP-1 antagonists, or other medications using online pharmacies can pose serious health risks. These sites are flush with substandard and falsified drugs, which can cause adverse side effects, leave serious conditions untreated, and, in some instances, lead to death. In this episode: Dr. Henry Michtalik shares how providers and patients can spot unregulated suppliers and report counterfeit drugs. Guest: Dr. Henry Michtalik, MHS, MPH, is a hospitalist at the Johns Hopkins University School of Medicine and an assistant professor at both the School of Medicine and the Bloomberg School of Public Health. He is a co-principal investigator with the School of Public Health's BESAFE initiative. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: Fake medication is a problem across the world—DW Fake Drugs, Real Danger—Hopkins Bloomberg Public Health Magazine Verify Before You Buy—National Association of Boards of Pharmacy Report a Counterfeit Drug—U.S. Food and Drug Administration Transcript Information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Let's say you were asked to name the greatest health risks facing the planet. Priceton University economist Ramanan Laxminarayan, founder and director of the One Health Trust, would urgently suggest you include anti-microbial resistance near the top of that list. “We're really in the middle of a crisis right now,” he tells interview David Edmonds in this Social Science Bites podcast. “Every year, about 5 million people die of infections that are associated with antibiotic resistance -- 5 million. That's nearly twice the number of people who die of HIV, TB and malaria, put together -- put together. Antibiotic resistance and associated deaths are the third leading cause of death in the world, after heart disease and stroke. So you're talking about something that's really, really big, and this is not in the future. It is right now.” The underlying problem, simply put, is that humans are squandering perhaps the greatest health innovations in the last century by using antibiotics stupidly, allowing pathogens to develop resistance and thus rendering existing antibiotics worthless. For the last 30 years and in particular through One Health Trust and as director of the World Health Organization Collaborating Center for Antimicrobial Resistance, Laxminarayan has labored to make both shine a light on anti-microbial resistance and push for policies to address it. This, he tells Edmonds, is a social science problem even more so than a medical science problem – but not the exclusive province of either. “I think one of the failures of economics,” he says, “in some ways, is that we don't take the trouble to understand the nitty gritty of the actual other field, especially when it deals with health economics or environmental economics.” In addition to his role as a senior research scholar at Princeton, Laxminarayan is an affiliate professor at the University of Washington, a senior associate at the Johns Hopkins Bloomberg School of Public Health, and a visiting professor at the University of Strathclyde.

About this episode: Breastfeeding plays a crucial role in babies' development and new research is even suggesting that breast milk can provide benefits to the microbiomes and immune systems of adults. In this episode: Meghan Azad, a breastfeeding researcher from the University of Manitoba, explains the chemical compounds that make human breast milk unique from other mammals, the opportunities to build more community support for breastfeeding, and the benefits of lactation for mothers. Guest: Meghan Azad, PhD, is a professor of pediatrics and child health at the University of Manitoba, where she leads a lab studying breastfeeding and breast milk. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: World Breastfeeding Week—World Health Organization New study reveals breastfeeding duration influences infant microbiome and respiratory development—UM Today Breast milk's benefits are not limited to babies—The Economist Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode:  Medicaid cuts from the recent budget reconciliation law are raising fears of cutbacks among Americans with disabilities who rely on the program for services that allow them to live independently. In this episode: Demi Eckhoff, who has a rare form of muscular dystrophy, and who relies on Medicaid in North Carolina, explains the uncertainty and what people with disabilities are doing to advocate for themselves. Guest: Demi Eckhoff, MPH, is a disability advocate, a registered dietitian, and an incoming doctoral student at the Johns Hopkins Bloomberg School of Public Health. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Disabled Americans Fear What Medicaid Cuts Could Do to Them—New York Times Five Ways the ‘One Big Beautiful Bill' Could Make It More Difficult to Get Health Insurance in N.C.—The Assembly America's Caregiver Crisis—Public Health On Call (July 2025) The Potential Impacts of Cuts To Medicaid—Public Health On Call (March 2025) Transcript information: Click here for a transcript of this episode. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Robert F. Kennedy Jr., the secretary of Health and Human Services, is eyeing an overhaul of two more key entities as part of his ongoing effort to reshape health policy. And President Donald Trump signed an executive order last week that would enable localities to force some homeless people into residential treatment.Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, and Shefali Luthra of The 19th join KFF Health News' Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Sara Rosenbaum, one of the nation's leading experts on Medicaid, to mark Medicaid's 60th anniversary this week. Plus, for “extra credit,” the panelists suggest health policy stories they read this week that they think you should read, too: Julie Rovner: KFF Health News' “Cosmetic Surgeries Led to Disfiguring Injuries, Patients Allege,” by Fred Schulte. Anna Edney: The Washington Post's “Morton Mintz, Post Reporter With a Muckraker Spirit, Dies at 103,” by Stefanie Dazio. Joanne Kenen: ScienceAlert's “New Kind of Dental Floss Could Replace Vaccine Needles, Study Finds,” by David Nield. Shefali Luthra: The New Yorker's “Mexico's Molar City Could Transform My Smile. Did I Want It To?” by Burkhard Bilger. Hosted on Acast. See acast.com/privacy for more information.

About this episode: The World Health Organization is reporting thousands of cases of malnutrition and 74 civilian deaths resulting from mass starvation in Gaza in 2025. In this episode: Dr. Paul Spiegel discusses the origins of the crisis and recent developments and shares what this dire situation means for the future of the international humanitarian system. Guest: Dr. Paul Spiegel is a physician, epidemiologist and the director of the Center for Humanitarian Health at the Johns Hopkins Bloomberg School of Public Health. Dr Spiegel has worked in humanitarian emergencies for the last 30 years. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: No Proof Hamas Routinely Stole U.N. Aid, Israeli Military Officials Say—New York Times Malnutrition rates reach alarming levels in Gaza, WHO warns—World Health Organization Humanitarian Health in Gaza and Beyond—Public Health On Call (June 2025) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: Since the 1980s, petrochemical production along an 85-mile stretch of the Mississippi River has designated the corridor as “Cancer Alley,” but recent research shows that the risks from air pollution in the region have been seriously underestimated. In this episode: Pete DeCarlo and Keeve Nachman of the Johns Hopkins University discuss their concerning findings about compounding chemical exposure on human health and explain what these conclusions mean for how the United States should regulate carcinogens. Guest: Pete DeCarlo, PhD, is an associate professor in Environmental Health and Engineering at the Johns Hopkins Whiting School of Engineering. Keeve Nachman, PhD, MHS, is the Robert S. Lawrence Professor in Environmental Health and Engineering at the Johns Hopkins Bloomberg School of Public Health. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs. Show links and related content: Air testing reveals cancer-causing gas levels far exceeding some government estimates—ABC News 4 Ethylene Oxide in Southeastern Louisiana's Petrochemical Corridor: High Spatial Resolution Mobile Monitoring during HAP-MAP—Environmental Science and Technology Surprisingly High Levels of Toxic Gas Found in Lousiana—The Hub Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: The United States stands at a pivotal juncture in eradicating HIV. Despite recent advancements, including the development of an effective new form of pre-exposure prophylaxis (PrEP), an uncertain future marked by cuts to Medicaid and research hurdles threatens to undo the country's progress. In this episode: Jeremiah Johnson, Executive Director of PrEP4All, sheds light on the urgent need for equitable access to PrEP and what's at stake if we fail to scale up initiatives to test, prevent, and treat HIV. Guest: Jeremiah Johnson is the Executive Director of PrEP4All—an organization that seeks to prevent the spread of HIV by identifying data-driven policy solutions to increase access to PrEP. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Trump's Policies Could Undermine the Fight to End America's HIV Epidemic—Tradeoffs FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option—CNBC Financing and Delivering Pre-Exposure Prophylaxis (PrEP) to End the HIV Epidemic—Journal of Law, Medicine & Ethics A National PrEP Program to End the Nation's HIV Epidemic—Public Health On Call (April 2022) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: In the 1980s, Colombian neurologist Francisco Lopera discovered a rare genetic mutation afflicting residents of a village outside Medellín that could hold the key to understanding and treating Alzheimer's disease. In this episode: Author Jennie Erin Smith talks about her new book Valley of Forgetting: Alzheimer's Families and the Search for a Cure and how families in the Paisa region of Colombia have forever changed the study of neurodegenerative diseases. Guest: Jennie Erin Smith is an author and a regular contributor for The New York Times, whose work has also appeared in The Wall Street Journal, The Times Literary Supplement, The New Yorker, and more. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: Valley of Forgetting: Alzheimer's Families and the Search for a Cure—Penguin Random House A Different Way to Think About Medicine's Most Stubborn Enigma—The Atlantic The ‘Country Doctor' Who Upended Our Understanding of Dementia—New York Times Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: The recent dismissal of all members of the CDC's Advisory Committee on Immunization Practices (ACIP) has stirred questions about vaccine safety and immunization protocols. In this episode: Dr. Grace Lee—a former ACIP chair—shares insights on the committee's crucial role in recommending vaccines uses, the importance of transparent decision-making, and dangers of abandoning strong processes. Guest: Dr. Grace Lee, MPH, is the Chief Quality Officer and the Christopher G. Dawes Endowed Director of Quality at Stanford Medicine Children's Health and Lucile Packard Children's Hospital Stanford, and Associate Dean for Maternal and Child Health (Quality and Safety) and Professor of Pediatrics at Stanford University School of Medicine. She previously served as the Chair of ACIP. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Former chairs of the Advisory Committee on Immunization Practices on the panel's role—STAT Who Decides Which Vaccines Americans Should Get and When?—Johns Hopkins Bloomberg School of Public Health Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

The Senate narrowly approved the Trump administration's request to claw back about $9 billion for humanitarian foreign aid projects and the Corporation for Public Broadcasting — but refused to cut funding for the international AIDS/HIV program PEPFAR. The House has a Friday deadline to approve the rescissions bill, or the funding remains in place. Meanwhile, a federal appeals court ruled that West Virginia can ban the abortion pill mifepristone, which could allow states to block other drugs approved by the FDA. Shefali Luthra of The 19th, Sandhya Raman of CQ Roll Call, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine join KFF Health News' Julie Rovner to discuss these stories and more. Plus, for “extra credit” the panelists suggest health policy stories they read this week that they think you should read, too: Julie Rovner: The New York Times' “UnitedHealth's Campaign to Quiet Critics,” by David Enrich. Joanne Kenen: The New Yorker's “Can A.I. Find Cures for Untreatable Diseases — Using Drugs We Already Have?” by Dhruv Khullar. Shefali Luthra: The New York Times' “Trump Official Accused PEPFAR of Funding Abortions in Russia. It Wasn't True,” by Apoorva Mandavilli. Sandhya Raman: The Nation's “‘We're Creating Miscarriages With Medicine': Abortion Lessons from Sweden,” by Cecilia Nowell. Hosted on Acast. See acast.com/privacy for more information.

About this episode: The deadly Fourth of July floods in Kerr County, TX are raising urgent concerns about flash flooding risks and the future of storm response. In this episode: Hurricane specialist and storm surge expert Michael Lowry discusses what causes increasingly intense storms, details the significant strides made in forecasting, and outlines what's at stake with potential cuts to NOAA. Guest: Michael Lowry is a hurricane specialist and storm surge expert for WPLG-TV in Miami, FL. He previously served as a senior scientist at the National Hurricane Center and as disaster planning chief at FEMA. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: Trying to Make Sense of the Unspeakable Texas Tragedy—Eye on the Tropics The Trump Administration Has Blinded Hurricane Forecasters—Intelligencer Critical Hurricane Monitoring Data Is Going Offline—New York Times Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode:  Artificial intelligence is changing everything about how we work, live, and study—and, now, AI therapy chatbots are poised to transform mental health care. In this episode: Stanford researcher Nick Haber details recent data that suggests that therapeutic AI has a long way to go in addressing biases and recognizing safety-critical situations in order to provide adequate care. Guest: Nick Haber, PhD, is an assistant professor at the Stanford Graduate School of Education, and by courtesy, Computer Science, where he researches AI implementation for learning and therapeutic tools. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs, the largest center at the Johns Hopkins Bloomberg School of Public Health. Show links and related content: Expressing stigma and inappropriate responses prevents LLMs from safely replacing mental health providers—FAccT '25: The 2025 ACM Conference on Fairness, Accountability, and Transparency Kids Are in Crisis. Could Chatbot Therapy Help?—New York Times Exploring the Dangers of AI in Mental Health Care—Stanford Institute for Human-Centered AI Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: For mothers questioning whether or not to vaccinate their children, the decision can be complicated by an overwhelming and, at times, conflicting information environment. In this episode: Health communication researcher Melissa Carrion explores how an onslaught of messaging is informing how mothers decide to vaccinate their kids and how public health experts can better communicate on these key decisions. Guest: Melissa Carrion, PhD, is an assistant professor of Writing and Rhetoric at the University of Nevada, Las Vegas, where she researches rhetoric and health communication. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: How one mom is navigating vaccines' uncertain future—ScienceNews New Research: Childhood Vaccination Rates Drop Across 1,600 U.S. Counties—The 74 "I Don't Understand How These Two Things Go Together": Toward a Theory of Risk Ecologies—Health Communication “You need to do your research”: Vaccines, contestable science, and maternal epistemology—Public Understanding of Science Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: Asthma can cause sometimes debilitating symptoms for children who have it, and some—particularly Black and Hispanic children—can experience higher rates of diagnoses, hospitalizations and emergency department visits. In this episode: pediatrician and immunology researcher Dr. Elizabeth Matsui talks about the known causes behind childhood asthma and how it impacts youths, and how factors like poor housing conditions and barriers to care and medication worsen conditions and undermine long-term lung development. Guest: Dr. Elizabeth Matsui is a pediatric allergist-immunologist and epidemiologist and a leading researcher on the connection between asthma and environmental conditions. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs at the Johns Hopkins Bloomberg School of Public Health. Show links and related content: The Role of Neighborhood Air Pollution in Disparate Racial and Ethnic Asthma Acute Care Use—American Journal of Respiratory and Critical Care Medicine Association of a Housing Mobility Program With Childhood Asthma Symptoms and Exacerbations—JAMA Do upper respiratory viruses contribute to racial and ethnic disparities in emergency department visits for asthma?—The Journal of Allergy and Clinical Immunology Tackling Housing Injustice—and Improving Childhood Asthma—Public Health On Call (June 2023) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University

About this episode: Caregivers—both paid and unpaid—are the silent backbone of the nation's workforce, providing crucial support to America's young, aging, and disabled populations. But 24 states stand on the precipice of crisis with looming threats to caregiver stipends, salaries, and other resources. In this episode: what led to this tipping point, how proposed cuts to Medicaid could make it worse, and how to build a more supportive system for caregivers, patients, and loved ones. Guest: Stacey B. Lee, JD is a professor of Law and Ethics at Johns Hopkins University's Carey Business School, with a joint appointment at the Bloomberg School of Public Health, where she specializes in business law, health law, and negotiations. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs at the Johns Hopkins Bloomberg School of Public Health. Show links and related content: Despite Political Divisions, U.S. Adults Across Parties Back Affordable Care, Support for Caregivers—Johns Hopkins Bloomberg School of Public Health Department of Health Policy and Management These Are The States On The Brink Of A Caregiver Crisis — And Trump Medicaid Cuts Could Make It Worse—HuffPost America's Unseen Workforce: The State of Family Caregiving—Columbia University Mailman School of Public Health The Forgotten Youths Who Are Caregivers For Their Families—Public Health On Call (April 2024) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: American farms, restaurants, retailers, and households throw out nearly 30% of the food in our system, landfilling millions of tons of food each year and draining resources like land and energy. Households generate the most waste, with everyday cooks overbuying at grocery stores and throwing away a substantial portion of their purchases—but getting ahead of those scraps can make a big difference. In this episode: ReFED's Dana Gunders covers the environmental costs of food waste and shares immediate action items to better manage it. Guest: Dana Gunders is a national food systems expert and the president of ReFED—an organization that researches and promotes evidence-based action to end food waste. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs at the Johns Hopkins Bloomberg School of Public Health. Show links and related content: From Surplus to Solutions: 2025 ReFED U.S. Food Waste Report—ReFED Marylanders toss out more than 1 million tons of food each year. How do we reduce waste?—WYPR From Farm to Kitchen: The Environmental Impacts of U.S. Food Waste—U.S. Environmental Protection Agency We Are Eating the Earth: The Race to Fix Our Food System—Public Health on Call (June 2025) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: Consumer wearables like Fitbits track a lot of our activity, from time spent standing to estimates of calorie expenditure. What if they could also alert us to possible health issues as we age? In this episode: How movement patterns change with aging, and how researchers are examining ways to measure those patterns to determine what's normal and what may be associated with cognitive decline and other neurological issues. Guest: Jennifer Schrack is the director of the Johns Hopkins Center on Aging and Health. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs at the Johns Hopkins Bloomberg School of Public Health. Show links and related content: The Mysteries of Aging Well—Hopkins Bloomberg Public Health Magazine Long-running Surveys Help Researchers Track Trends In Aging—The Hub How Well Will You Age? Check Your Grip Strength—Time Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: Growing and producing our food comes at an extreme cost to the environment. In this episode: a conversation about climate and agriculture with journalist and author Michael Grunwald, whose blunt new book looks at how the food system is wiping out wetlands, forests, and other carbon reservoirs that protect us from global warming. Guest: Michael Grunwald is a journalist and author who covers public policy. He's written for Politico Magazine, The Boston Globe, and Washington Post, and Time. His new book is We Are Eating The Earth: The Race to Fix Our Food System. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: A Food Reckoning Is Coming—The Atlantic Changing How We Grow Our Food—The New York Times (Opinion) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: What might be in store for the 2025 hurricane season? Meterologist Brian McNoldy returns to the podcast to talk about how things are shaping up, a look back at how last summer's unprecedented mix of heat and moisture played out in an extremely active season, and a zoomed-out look at climate change trends as larger patterns beyond individual events and year-over-year comparisons. Guest: Brian McNoldy is a senior research associate at the Rosenstiel School of Marine Atmosphere and Earth Science at the University of Miami. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: Meteorology and Climate Change—Public Health On Call (July 2024) Get ready for several years of killer heat, top weather forecasters warn—AP ‘Bomb cyclone' adds to growing extreme weather trend—News@TheU (2024

On Food Talk with Dani Nierenberg, Dani speaks with Amesh Adalja, a Senior Scholar at the Johns Hopkins Center for Health Security and an Adjunct Assistant Professor at the Johns Hopkins Bloomberg School of Public Health. They discuss the outbreak of avian flu on poultry and dairy cattle farms, the federal funding cuts that are weakening government agencies' ability to track and prevent the spread of the virus, and why the lack of proactivity is cause for concern. While you're listening, subscribe, rate, and review the show; it would mean the world to us to have your feedback. You can listen to “Food Talk with Dani Nierenberg” wherever you consume your podcasts.

About this episode: Juneteenth was declared a federal holiday in 2021 but many people don't know the history or how to recognize the day. In this episode: a look back at a 2022 conversation with Janice Bowie about how to celebrate, reflect, and recommit to social justice this Juneteenth. Guest: Janice Bowie is a Bloomberg Centennial Professor in Health, Behavior, and Society at the Johns Hopkins Bloomberg School of Public Health. Her research focuses on health equity and disparities. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Juneteeth: Sun, Sounds and the Spirit of Freedom—Smithsonian Instutition Juneteenth National Independence Day Act—Congress.gov 9 Places to Celebrate Juneteenth This Year—The New York Times Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: Homicides in the U.S., particularly those involving gun violence, peaked in 2022 following a rapid rise during the COVID pandemic. In the years that followed, there were notable decreases and 2025, so far, shows one of the most dramatic reductions in homicides in decades. In this episode: A look at some of the reasons behind the rise and fall of deaths, and why staying the policy course may be key to avoiding another spike. Guest: Daniel Webster is a Bloomberg Professor of American Health who has studied gun violence and prevention for more than thirty years. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Deadly decisions? Trump guts anti-crime program as summer violence looms—USA Today Supreme Court upholds Biden regulations on ‘ghost gun' kits—NBC News City of Baltimore Reaches Settlement in Polymer80—Mayor Brandon Scott, Baltimore City A Safer Gun Buying Process—Public Health On Call (February 2025) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: Humanitarian health systems provide relief like food, water, and medicine in crisis situations. They operate within a carefully organized framework built on core principles including impartiality and neutrality. In this episode: what's happening with humanitarian aid in Gaza and the importance of a new framework for global humanitarian efforts. Guest: Dr. Paul Spiegel is a physician, epidemiologist and the director of the Center for Humanitarian Health at the Johns Hopkins Bloomberg School of Public Health. Dr Spiegel has worked in humanitarian emergencies for the last 30 years. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Group Accuses Hamas of Threatening Aid Workers in Gaza—The New York Times A Flawed Attempt at Delivering Gaza Aid Led to a Wave of Deaths—The Wall Street Journal (paywall) The Humanitarian Response in Gaza—Public Health On Call  (January 2024) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: In 2016, the nonprofit Braver Angels was founded to bring together diverse groups of people to try and figure out why productive communication has become so difficult. During the pandemic, the conversations got even harder. In this episode: How Braver Angels is bringing together questioners and supporters of public health to hear each other out with a goal of humanizing, understanding, and remembering that “everyone is worth listening to.” Guests: Dr. Leslie Lapato is a retired psychiatrist who has worked with Braver Angels since 2017 in a variety of roles including alliance chair, debate chair, debate whip, moderator, and organizer.   Dr. Beth Malow is a neurology sleep physician and science communicator who has worked with Braver Angels since 2017 in a variety of roles including moderator, workshop designer, and debate chair. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Our Mission—Braver Angels Confronting our COVID condescension—Braver Angels Colorado Springs company works with Braver Angels to promote civility through debates—The Gazette Braver Angels spreads its ‘building bridges' gospel across Greater Minnesota—MinnPost Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Health and Human Services Secretary Robert F. Kennedy Jr. this week did something he had promised not to do: He fired every member of the scientific advisory committee that recommends which vaccines should be given to whom. And he replaced them, in some cases, with vaccine skeptics. Meanwhile, hundreds of employees of the National Institutes of Health sent an open letter of dissent to the agency's director, Jay Bhattacharya, accusing the Trump administration of policies that “undermine the NIH mission, waste our public resources, and harm the health of Americans and people across the globe.” Anna Edney of Bloomberg News, Sarah Karlin-Smith of the Pink Sheet, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine join KFF Health News' Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Douglas Holtz-Eakin, president of the American Action Forum and former director of the Congressional Budget Office, to discuss how the CBO works and why it's so controversial. Plus, for “extra credit,” the panelists suggest health policy stories they read this week that they think you should read, too: Julie Rovner: Stat's “Lawmakers Lobby Doctors To Keep Quiet — or Speak Up — on Medicaid Cuts in Trump's Tax Bill,” by Daniel Payne. Joanne Kenen: ProPublica's “DOGE Developed Error-Prone AI Tool To ‘Munch' Veterans Affairs Contracts,” by Brandon Roberts, Vernal Coleman, and Eric Umansky. Anna Edney: KFF Health News' “Two Patients Faced Chemo. The One Who Survived Demanded a Test To See if It Was Safe,” by Arthur Allen. Sarah Karlin-Smith: Wired's “The Bleach Community Is Ready for RFK Jr. To Make Their Dreams Come True,” by David Gilbert. Hosted on Acast. See acast.com/privacy for more information.

Dr. Jim McDonald, commissioner of the New York State Department of Health, discusses the State's Heat Risk and Illness Dashboard and how it can reduce heat related injury; Dr. Tara Kirk Sell, senior scholar at the Johns Hopkins Center for Health Security and an associate professor in the Department of Environmental Health and Engineering at the Johns Hopkins Bloomberg School of Public Health, previews public health communications topics that will be covered in ASTHO's INSPIRE Readiness webinar today, Thursday, June 12 at 2 p.m. ET; the Texas Department of State Health Services is leading an initiative to strengthen collaboration between public health and academic health departments; and ASTHO member Dr. Ralph Alvarado, commissioner of the Tennessee Department of Health, was a panelist at the Age-Friendly Ecosystem Summit, where he discussed the importance of effective public health messaging.  New York State Department of Health Heat Risk and Illness Dashboard News Release: New York State Department of Health Launches Interactive Heat Risk and Illness Dashboard ASTHO Webinar: INSPIRE: Readiness - Tackling Public Health Communication Conundrums: Rumors and Public Trust  ASTHO Blog: Public Health and Academic Leaders Unite Through Texas Consortium Trust for America's Health and John A. Harford Foundation: The Age-Friendly Ecosystem Summit  

About this episode: A recent MAHA report from the Department of Health and Human Services stated that a trio of common procedures for children—tonsillectomy, adenoidectomy, and tympanostomy tube (ear tube) placement—“cause harm without offering benefits.” In this episode: a look at what these surgeries are, the advantages and risks, and what the report said—and didn't say—about the value of these procedures when properly indicated. Guests: Dr. Emily Boss is the director of pediatric otolaryngology at Johns Hopkins. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: The MAHA Report: Make Our Children Health Again—The White House MAHA kids' health report misinforms about tonsillectomies and ear tubes—STAT (Opinion) Tympanostomy Tubes or Medical Management for Recurrent Acute Otitis Media—The New England Journal of Medicine Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: Would it be a good idea to have tariffs on pharmaceuticals? In this episode: a conversation about the rationales for tariffs as well as potential downsides—like higher drug prices—and what could really help with supply and pricing issues. Guest: Dr. Mariana Socal studies the pharmaceutical market and is an associate professor in Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Tariffs as a Hidden Tax: Price Pass-Through in Multi-Stage Supply Chains—Johns Hopkins Carey Business School Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages—NBC Los Angeles Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: A new report from the Safeguarding Health in Conflict Coalition documents incidents of violence against health care facilities and workers in conflict zones around the world. In this episode: why it's important to track these trends, how incidents are reported and investigated, and a look at the 2024 report with examples from various conflict zones around the world including Sudan, Ukraine, and Gaza. Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University. Guests: Joe Amon is the director of the Johns Hopkins Center for Public Health and Human Rights. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Safeguarding Health in Conflict Coalition, 2024 Report Allegations of War Crimes by Leaders of Hamas and Israeli Officials Before the International Criminal Court—Public Health On Call (June 2024) Human Rights and Health Care in the Middle East Crisis—Public Health On Call (December 2023) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: June is Gun Violence Awareness Month with a focus on safe storage, a key factor in preventing gun-related injuries and deaths. In this episode: a look at how safe storage saves lives, evidence-based tools and tips for lawmakers, gun owners, parents, pediatricians, and more; and how to normalize conversations about safe storage in everyday life. Guests: Dr. Katherine Hoops, is a pediatrician and the director of Clinical Practice at the Johns Hopkins Center for Gun Violence Solutions. Cass Crifasi is the co-executive director at the Johns Hopkins Center for Gun Violence Solutions. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: Gun Violence Awareness Month Campaign—The Center For Gun Violence Solutions Safe & Secure Gun Storage Prevents Injuries (PDF) How To Talk To Other Parents About Guns In The Home (PDF) Safe and Secure Gun Storage Solutions—The Center For Gun Violence Solutions What The Conviction of a Parent of a High School Shooter Could Mean—Public Health On Call (March 2024) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: Last week, Health Secretary Robert F. Kennedy, Jr., announced that the COVID vaccine will no longer be recommended for healthy children or pregnant women. In this episode: a vaccine policy expert unpacks the announcement — how it differs from past policy changes, and its potential impact on Americans. Note: This episode was recorded on May 28, 2025. Guest: Sarah Despres has over 25 years of experience in public health policy and advocacy and is an expert on immunization policy. She has served on the HHS National Vaccine Advisory Committee from 2012-2017. She has also served on the board of Vaccinate Your Family, a nonprofit dedicated to ensuring children and adults have access to vaccines. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: U.S. Will No Longer Recommend Covid Shots for Children and Pregnant Women—The New York Times Who Decides Which Vaccines Americans Should Get and When?—Johns Hopkins Bloomberg School of Public Health (March 2025) Pediatric COVID Vaccines—Public Health On Call (May 2025) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.  

About this episode: Travel can open our eyes to the world and make us better global citizens. But there's no denying the environmental impacts of travel. Plus, with climate change happening everywhere, it's becoming more difficult for tourists to predictably see and do some things without factoring in extreme weather. In this episode: how travelers can be more mindful and a look at how a travel company is thinking about the industry's carbon footprint. Guest: Cameron Hewitt is a travel writer and photographer, and for the last 25 years he's been a co-writer for Rick Steves' Europe, one of the biggest names in travel for guidebooks, public television, radio, and tours. You can follow his adventures on Instagram and Facebook. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: Our Climate Smart Commitment—Rick Steves' Europe How a traveler's mindset can grow your understanding—Rick Steves, TEDxSeattle Salon Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

On May 20th, after years of negotiation, World Health Organization member states adopted the Pandemic Agreement — the first international treaty focused on pandemic prevention, preparedness, and response. Developed in response to the shortcomings revealed during the COVID-19 pandemic, the agreement emphasizes equitable access to vaccines, diagnostics, and treatments, and promotes international cooperation in disease surveillance and health system strengthening. But will this brand-new agreement live up to its potential? And what role might the United States' decision to remain on the sidelines — and not become a party to the agreement — play in how it is adopted and implemented? Joining me to discuss these questions and more is Alexandra Phelan, Associate Professor at the Johns Hopkins Bloomberg School of Public Health and Senior Scholar at the Johns Hopkins Center for Health Security. We begin by examining how the deficiencies in the global response to COVID-19 revealed the need for such a treaty in the first place, before having a longer conversation about what the agreement actually obliges of its signatories — and what factors will determine whether or not it works as intended.   This episode is produced in partnership with Lex International Fund, a philanthropic fund dedicated to strengthening international law to solve global challenges. It is part of a series that demonstrates the impact of Treaties on state behavior that we are calling "when treaties work"

Fungal diseases are becoming more common, more dangerous, and more difficult to treat. There's concern that they may cause the next global pandemic. Rising global temperatures, better survival rates for vulnerable patients, and increased medical interventions contribute to the rise in fungal infections. Access to effective diagnostics and treatment remains limited, with significant disparities between high and low-income countries. Treating fungal infections is becoming more challenging as they build resistance to the drugs used to treat them. New therapies are being developed, including treatments that disrupt fungal DNA replication or interfere with essential proteins, offering some hope for long-term control.Contributors: Adilia Warris, Professor in Paediatric Infectious Diseases, University of Exeter, UKRita Oladele, Professor of Clinical Microbiology, University of Lagos and Lagos University Teaching Hospital, NigeriaArturo Casadevall, Professor and Chair of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, USMichael Bromley, Professor in Fungal Disease, University of Manchester, UKPresenter: Tanya Beckett Producer: Louise Clarke Researcher: Maeve Schaffer Editor: Tara McDermott Technical Producer: Richard Hannaford Production co-ordinator: Tammy Snow(Image: Aspergillus fumigatus, seen under an optical microscope. Credit: BSIP/Education Images/Universal Images Group via Getty Images)

About this episode: The approval of pediatric COVID vaccines during the height of the pandemic brought reassurance to many parents and pediatricians who were caring for children with severe infections and, sometimes, Multi-system Inflammatory Syndrome in Children (MISC)—a rare but extremely dangerous condition that could impact even the healthiest kids after a COVID infection. But what's the picture of pediatric COVID vaccination now? In this episode: a discussion about the risks and benefits of pediatric COVID vaccination in 2025. Guest: Dr. Erica Prochaska is a pediatric infectious disease physician at Johns Hopkins School of Medicine. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: New FDA framework on Covid vaccines leaves pediatricians confused and concerned—STAT News A Pediatric Cardiologist on What We Know—And Don't Know—About COVID-19-Related Multi-System Inflammatory Syndrome in Children—Public Health On Call (June 2020) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: A look inside the ongoing public health response to measles outbreaks in Lubbock, a city in West Texas. Guest: Katherine Wells is the director of Lubbock Public Health in West Texas. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Lubbock's public health director fights to stop measles and build public trust—The Texas Tribune Texas Isn't Declaring a Measles Victory Yet—Bloomberg Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: It's graduation time at the Bloomberg School! Doctoral candidate Jeff Marr joins the podcast to talk about how an economics major and an early internship at a health care system led to an interest in examining how health care markets and public policy work. Soon-to-be Dr. Marr discusses his dissertation looking at how predictive algorithms lead to decisions about care coverage. Guest: Jeffrey Marr is a healthcare economist and doctoral candidate at the Johns Hopkins Bloomberg School of Public Health. In July 2025, he will join Brown University as an Assistant Professor of Health Services, Policy, and Practice. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Algorithmic Decision-Making in Health Care: Evidence from Post-Acute Care in Medicare Advantage Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.